Contrarian Stock Market Investing News - Featuring Bargain Stocks » SVA

Take 26% Gains on Indian Pharma Giant Dr. Reddy’s (RDY)

J. Christoph Amberger — Fri, 25 Sep 2009 20:02:52 +0000

It’s a rainy day and the markets are all but inspiring. So take gains on Dr. Reddy’s Laboratories Limited (NYSE:RDY) and buy yourself a cuppa cheer!

Don’t tell me we’re not doing anything for readers of of free service, the TFN eNews, and visitors of our TFN home page.

On August 20, we posted a free TFN Special Report, The Top Swine Flu Vaccine Stocks under $20, in which we recommended three stocks.

One of them, Sinovac (AMEX:SVA), gave us 30% gains on Aug. 28.

Today, the arguably largest and slowest-moving of the pig flu trip stepped on the gas. On Aug. 20, I recommended you “buy Dr. Reddy’s Laboratories Limited (NYSE:RDY) under $16.50 for possible gains of 10-15% throughout 2010.”

Today, our Indian generics wallah is trading at $20.43. In our TFN tracking portfolio, this clocks in as a 25.95% gain.

I say we take it!

Source: Take 26% Gains on Indian Pharma Giant Dr. Reddy’s (RDY)

First Gains on Swine Flu Vaccine Stocks

J. Christoph Amberger — Wed, 26 Aug 2009 21:04:09 +0000

Pre-pandemic profits on Sinovac (AMEX:SVA) Vical Incorporated (NASDAQ:VICL), and Dr. Reddy’s Laboratories (NYSE:RDY)?
Six days ago, on Aug. 20, I sent out our TFN Special Report: The Top Swine Flu Vaccine Stocks under $20. You know the kind of reports I write: Full of useless asides and rambling observations about the vices of the current Administration. In fact, I almost forgot to give you the three free swine flu stock picks I had planned on. That would’ve been a pity because today

Sinovac Biotech Ltd. (AMEX:SVA) is up 30.00%…

Vical Incorporated (NASDAQ:VICL) is up 16.05%…

Even staid-and-steady Indian generics brahmin Dr. Reddy’s Laboratories (NYSE:RDY) is up 3.64%…

No moonshoots, for sure, but 30% in six days beats getting getting your chest waxed. (Or so I’ve heard.)

(The pig flu picks I reserved for our HSC members were a bit smaller… and just a tad more risky. That risk’s been paying off for one stock that shot up over 20% today, for total gains of over 40% in less than a week. But I’m digging in and holding for more..)

Source: First Gains on Swine Flu Vaccine Stocks

Sinuvac (SVA) Reports Swine Flu Success

J. Christoph Amberger — Tue, 18 Aug 2009 22:30:43 +0000

The unexpected absence of the Chinese fencing coach can only be due to one thing: Sinuvac’s (AMEX:SVA) reported a breakthrough with their new anti- H1N1 swine flu vaccine!

When I asked Bin Lu, my Chinese fencing coach, earlier this summer if he’d be embarking on his annual pilgrimage to China this summer, he seemed dubious.

“Afraid they put me in quarantine,” he said. “Swine flu.”

Indeed, his hesitation seemed reasonable: A volleyball team from my son’s high school spent most of their trip to China locked up in a Beijing hotel. And the Kawasaki delegation of Japanese scouts that part of our Boy Scout troop had been preparing to host for the better part of a year canceled their visit for fear of the porcine virus.

So I knew I was facing a turning point last night when I heard that Coach Bin had left for Shanghai, sticking me with a bunch of kids signed up for fencing lessons on Thursday night.

The news today confirmed my suspicions:

Sinovac Biotech Ltd. (AMEX:SVA) has developed a swine flu vaccine that is now safe. According to reports, it protects people after a single shot.

Inoculation has caused no severe adverse reactions in the 1,614 volunteers who received it, according to the company.

“The results are the first reported anywhere in the world on a vaccine to fight the new H1N1 strain that’s sparked the first influenza pandemic in 41 years,” said the company.

With U.S. vaccine manufacturers already behind schedule producing the amounts of vaccine ordered up by the U.S. government, that means Sinovac has the inside track on the world H1N1 vaccine market.

The stock rose over 10% today. Keep an eye on the stock… if U.S. manufacturers are not catching up, this one may be a medium-term winner.

Source: Sinuvac (SVA) Reports Swine Flu Success